Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies
about
Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-octulosonate region of bacterial lipopolysaccharideA broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharidesCritical appraisal of therapeutic interventions in the intensive care unit: human monoclonal antibody treatment in sepsis. Journal Club of the Hamilton Regional Critical Care Group.An alternative pathway for preclinical research in fluid managementEfficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsisAntibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum.Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides.Novel therapies for sepsis: antiendotoxin therapies.Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniaeMonoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection.Immortalisation of human antibody producing cells.A murine monoclonal antibody defines a unique epitope shared by Klebsiella lipopolysaccharides.Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis.The birth pangs of monoclonal antibody therapeutics: the failure and legacy of CentoxinMonoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.Interleukin 10 protects mice from lethal endotoxemiaCellular mechanisms in sepsis.Purification and characterization of lipooligosaccharides from four strains of "Haemophilus somnus"Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificityCarumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.Human monoclonal antibody against endotoxin.E5 monoclonal immunoglobulin M antibody for the treatment of gram-negative sepsis.Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.Innate immune recognition and inflammation in Neisseria meningitidis infection.Anti-lipid A monoclonal antibody centoxin (HA-1A) binds to a wide variety of hydrophobic ligands.Genetically engineered antibody molecules: new tools for cancer therapy.Antibody immunotherapy of gram-negative bacterial sepsis.In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.Polyspecificity of Anti-lipid A Antibodies and Its Relevance to the Development of Autoimmunity.Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.Protective ability and specificity of convalescent serum from calves with Haemophilus somnus pneumonia.Endotoxin Entrapment on Glass via C-18 Self-Assembled Monolayers and Rapid Detection Using Drug-Nanoparticle Bioconjugate Probes.Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.Characterization of specific binding of a human immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain.Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.Recognition of auto- and exoantigens by V4-34 gene encoded antibodies.
P2860
Q28337638-2682498C-EF57-42BB-B05D-FE36FF8D0078Q33608312-2AA9FE13-846E-4E0C-896D-6A9CACBBC5CBQ33857147-1B3C305D-9AAD-43BC-95AA-C3840F6C34B0Q34187790-A220F863-0E23-41F6-BB82-B4AEC99513ECQ34198040-F16D98E7-C659-4CE9-A884-787A35BB68C6Q34523549-DD25D444-06FA-4E3F-9E6A-4A82870119DCQ34546868-B57C412D-54D4-4664-8720-6BDA6FD69B35Q34572019-96D49C57-7984-4C5E-8BC5-C9A1902F53BBQ35011910-8AFB3341-6E85-42EA-BEDF-9B6484CD332FQ35103543-3E533D5B-C1D0-4E09-B086-EE25C1E8D63FQ35110825-646049EE-B81D-440E-8345-1D88136D38B4Q35237160-D3B2FBE6-E0CF-4E10-9FEC-9EBBD940C293Q35776524-2F23CED4-3406-407D-AFCA-A30F0E4FDCE1Q35897129-4A168D37-180A-45FC-A7D3-C9FD3C3B5DC8Q35969881-672E29F4-596F-4DC8-B422-69E158B2A5C3Q35980641-C4B09AED-3B36-48FD-B943-5FFCADB4E8BCQ36350739-DC7FCF6F-5543-44BA-AF29-DA146287DE6CQ36361146-3D83FBFA-A1C0-43B0-8793-346FF02F5959Q36361558-1841753A-7BD9-4E14-AE25-FB805709FA74Q36800701-CA8C8870-7778-4606-BC63-3B41C2B0EF08Q37000511-0C158603-AB81-4CCD-8990-742A31C3AFAFQ37017748-CF928812-4A02-4B86-89B3-0D82313E9181Q37214347-95453AC7-9308-49C3-91E7-555427C4FDB8Q37366045-E4E4EE30-0270-4654-825B-4D41F8D521B6Q37508824-E7D05D5D-20C4-4E90-B047-585DD9EAFDF4Q37508833-FFB4C5B4-15CF-4FDC-9AA2-15BA503E87B7Q38342096-95CFEF26-A060-482A-98E7-A56CC38CD6DDQ39196108-22992E49-14BA-4C84-9ACE-A15F12AF9DDCQ39570180-BF3757C6-E71E-481E-B02A-15E2CFD3ADE3Q39644773-164C1AA3-59AD-4055-B75C-1D53A59CC8B1Q39660122-B6A57280-4115-46D1-9600-97CBA03BAC60Q39730722-AE767A46-A356-45C4-A897-60FB8EC6C8AFQ40059466-2E057A72-4360-493A-98F5-91A7508DA1A5Q40146784-8FEC529F-DEF2-43E5-A290-9A733E31D8F5Q40163375-92BF0A66-CDCC-49CF-8210-8C9F39C1382CQ40223673-4079FED5-1176-4C83-B890-1297BD720F0CQ40266864-473DE49A-A98D-477F-B895-C8EC45AE0B20Q40374233-649D4F25-6DCD-41B8-A516-71287350A509Q40375309-556142B1-75F1-4923-8E8C-4750B13FDEE3Q40903369-3C5C2876-85D9-40E1-BD07-63EB26F2CD61
P2860
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protection against gram-negati ...... uman monoclonal IgM antibodies
@en
Protection against gram-negati ...... man monoclonal IgM antibodies.
@nl
type
label
Protection against gram-negati ...... uman monoclonal IgM antibodies
@en
Protection against gram-negati ...... man monoclonal IgM antibodies.
@nl
prefLabel
Protection against gram-negati ...... uman monoclonal IgM antibodies
@en
Protection against gram-negati ...... man monoclonal IgM antibodies.
@nl
P2093
P2860
P356
P1476
Protection against gram-negati ...... uman monoclonal IgM antibodies
@en
P2093
A I Braude
A Wunderlich
H S Kaplan
J M Hebert
P2860
P304
P356
10.1073/PNAS.82.6.1790
P407
P577
1985-03-01T00:00:00Z